Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Proceedings of the National Academy of Sciences of the United States of America|October 16, 2023
Biphasic decay of intact SHIV genomes following initiation of antiretroviral therapy complicates analysis of interventions targeting the reservoirMithra R Kumar, Emily J Fray, Alexandra M Bender, et al.
Plos Computational Biology|April 4, 2023
Mathematical modeling of plus-strand RNA virus replication to identify broad-spectrum antiviral treatment strategiesCarolin Zitzmann, Christopher Dächert, Bianca Schmid, et al.
Biorxiv : the Preprint Server for Biology|August 4, 2022
Mathematical modeling of plus-strand RNA virus replication to identify broad-spectrum antiviral treatment strategiesCarolin Zitzmann, Christopher Dächert, Bianca Schmid, et al.
Biorxiv : the Preprint Server for Biology|November 14, 2023
Last in first out: SIV proviruses seeded later in infection are harbored in short-lived CD4+ T cellsNarmada Sambaturu, Emily J Fray, Fengting Wu, et al.
Cell Reports|May 6, 2025
SIV proviruses seeded later in infection are harbored in short-lived CD4+ T cellsNarmada Sambaturu, Emily J Fray, Vivek Hariharan, et al.
Biorxiv : the Preprint Server for Biology|September 25, 2023
Modeling the emergence of viral resistance for SARS-CoV-2 during treatment with an anti-spike monoclonal antibodyTin Phan, Carolin Zitzmann, Kara W Chew, et al.
Plos Pathogens|April 18, 2024
Modeling the emergence of viral resistance for SARS-CoV-2 during treatment with an anti-spike monoclonal antibodyTin Phan, Carolin Zitzmann, Kara W Chew, et al.
Cell Host & Microbe|February 22, 2023
Antiretroviral therapy reveals triphasic decay of intact SIV genomes and persistence of ancestral variantsEmily J Fray, Fengting Wu, Francesco R Simonetti, et al.
Nature Communications|December 15, 2021
Convergent use of phosphatidic acid for hepatitis C virus and SARS-CoV-2 replication organelle formationKeisuke Tabata, Vibhu Prasad, David Paul, et al.
The Journal of Experimental Medicine|December 5, 2025
Dynamics of natural and pharmacologic control of an SIV variant with an envelope trafficking defectKyle Rhodehouse, Carolin Zitzmann, Meghana Ravi, et al.
Pageof 3